Drug
Gacyclidine clinical trials
Also written OTO-313.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Otonomy, Inc. (2) · NeuroSystec Corporation (1)
Related medicines
As reviewed, each with the page that says it.
- One of Neuroprotective Agents source
Studies
Open first, then newest update. How each study uses gacyclidine is read from its arms, and is right about nine times in ten.
Testing it · 3
- OTO-313 in Subjects With Unilateral Subjective TinnitusCompletedPhase 2Otonomy, Inc.NCT04829214Written as OTO-313
- OTO-313 in Subjects With Subjective TinnitusCompletedPhase 1/2Otonomy, Inc.NCT03918109Written as OTO-313
- Safety Study for NST-001 and the Neuroject Injection Set to Treat TinnitusTerminatedPhase 1NeuroSystec CorporationNCT00957788Written as NST-001
Codes
What other systems call gacyclidine · ClinicalTrials.gg INT003588
- MeSH (NLM) C070707gacyclidineConfirmed NLM, Wikidata
- UNII (FDA) 9290ND070RGACYCLIDINEConfirmed FDA, NLM, Wikidata
- Wikidata Q13560447gacyclidineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76779GacyclidineOne source FDA
- DrugBank DB13096One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C070707 | gacyclidine | Confirmed NLM, Wikidata |
| UNII (FDA) | 9290ND070R | GACYCLIDINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q13560447 | gacyclidine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76779 | Gacyclidine | One source FDA |
| DrugBank | DB13096 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.